Narrative Update • Jun 06
Have your own idea? Try our Stock Screener
German (DAX) Pharma Industry Analysis
UpdatedJun 08, 2026
DataAggregated Company Financials
Companies8
- 7D3.8%
- 3M8.6%
- 1Y24.3%
- YTD5.9%
In the last week, the Pharma industry is up 2.3%, with Merck KGaA up 4.6%. This means that the industry has gained 25% over the past year. Earnings are forecast to grow by 22% annually.
Industry Valuation and Performance
Has the German Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 08 Jun 2026 | €98.1b | €67.4b | €482.5m | 23.5x | 203.4x | 1.5x |
| Wed, 06 May 2026 | €88.3b | €67.9b | -€888,701,746.33 | 18x | -99.3x | 1.3x |
| Fri, 03 Apr 2026 | €89.9b | €67.9b | -€900,269,345.66 | 20.1x | -99.9x | 1.3x |
| Sun, 01 Mar 2026 | €99.9b | €68.3b | €2.9b | 18.7x | 34.8x | 1.5x |
| Tue, 27 Jan 2026 | €104.1b | €68.3b | €2.9b | 17.7x | 36.4x | 1.5x |
| Thu, 25 Dec 2025 | €90.6b | €68.3b | €2.9b | 17.8x | 31.6x | 1.3x |
| Sat, 22 Nov 2025 | €78.9b | €68.5b | €2.9b | 16.5x | 27.4x | 1.2x |
| Mon, 20 Oct 2025 | €78.1b | €68.8b | -€439,012,678.07 | 19.5x | -178x | 1.1x |
| Wed, 17 Sep 2025 | €75.8b | €68.9b | -€406,209,055.83 | 16.9x | -186.6x | 1.1x |
| Fri, 15 Aug 2025 | €77.5b | €68.9b | -€409,982,550.74 | 17x | -189x | 1.1x |
| Sun, 13 Jul 2025 | €78.3b | €69.4b | -€283,071,598.00 | 17.6x | -276.8x | 1.1x |
| Tue, 10 Jun 2025 | €79.0b | €69.4b | -€206,268,848.00 | 18.5x | -383.1x | 1.1x |
| Thu, 08 May 2025 | €78.4b | €69.3b | €463.8m | 18.8x | 169x | 1.1x |
| Sat, 05 Apr 2025 | €73.5b | €69.3b | €467.0m | 17.6x | 157.3x | 1.1x |
| Mon, 03 Mar 2025 | €84.1b | €69.2b | €2.0b | 21.9x | 41.5x | 1.2x |
| Wed, 29 Jan 2025 | €86.9b | €69.2b | €2.0b | 23.8x | 42.9x | 1.3x |
| Fri, 27 Dec 2024 | €81.1b | €69.2b | €2.0b | 22.2x | 40.4x | 1.2x |
| Sun, 24 Nov 2024 | €83.7b | €69.2b | €2.0b | 22.3x | 41.3x | 1.2x |
| Tue, 22 Oct 2024 | €98.3b | €69.4b | €1.6b | 21x | 63x | 1.4x |
| Thu, 19 Sep 2024 | €102.3b | €69.4b | €1.5b | 25.1x | 70.1x | 1.5x |
| Sat, 17 Aug 2024 | €103.8b | €69.3b | €1.5b | 31x | 71.2x | 1.5x |
| Mon, 15 Jul 2024 | €96.1b | €69.2b | -€303,627,757.00 | 29.4x | -316.3x | 1.4x |
| Wed, 12 Jun 2024 | €103.9b | €69.2b | -€328,028,608.00 | 22.6x | -316.8x | 1.5x |
| Fri, 10 May 2024 | €98.4b | €70.0b | -€71,372,519.94 | 20.4x | -1379.4x | 1.4x |
| Sun, 07 Apr 2024 | €95.3b | €70.0b | -€34,208,180.00 | 20.6x | -2786.2x | 1.4x |
| Tue, 05 Mar 2024 | €98.9b | €70.6b | -€650,504,143.00 | 19.7x | -152.1x | 1.4x |
| Thu, 01 Feb 2024 | €97.4b | €70.6b | -€647,396,793.00 | 22.4x | -150.4x | 1.4x |
| Sat, 30 Dec 2023 | €98.5b | €70.6b | -€650,606,256.00 | 19.8x | -151.4x | 1.4x |
| Mon, 27 Nov 2023 | €104.6b | €70.6b | -€653,407,256.00 | 19.8x | -160.2x | 1.5x |
| Wed, 25 Oct 2023 | €105.8b | €72.1b | €4.7b | 17.8x | 22.6x | 1.5x |
| Fri, 22 Sep 2023 | €119.4b | €72.1b | €4.7b | 22x | 25.6x | 1.7x |
| Sun, 20 Aug 2023 | €121.8b | €72.1b | €4.7b | 22.5x | 26x | 1.7x |
| Tue, 18 Jul 2023 | €117.0b | €74.1b | €6.5b | 18.1x | 18.1x | 1.6x |
| Thu, 15 Jun 2023 | €127.2b | €74.1b | €6.4b | 22.6x | 19.8x | 1.7x |
Price to Earnings Ratio
19.8x
Current Industry PE
- Investors are optimistic on the German Pharmaceuticals industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 203x which is higher than its 3-year average PE of 128x.
- The industry is trading close to its 3-year average PS ratio of 1.3x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have declined 58% per year over the last three years,
- Revenues have also declined 3.1% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the German Healthcare industry?
| DE Market | -1.25% | |
| Healthcare | 2.50% | |
| Pharma | 3.76% | |
| Pharma | 3.76% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| MRK Merck KGaA | €136.85 | 4.6% +€2.6b | 18.1% | PE23.5x | |
| BAYN Bayer | €36.16 | 2.9% +€1.0b | 36.5% | PS0.8x | |
| DMP Dermapharm Holding | €47.55 | 0.8% +€19.8m | 29.0% | PE16.3x | |
| 93M1 MPH Health Care | €26.10 | 0.8% +€856.3k | 38.5% | PS2.2x | |
| B8FK Biofrontera | €2.59 | 5.3% +€790.0k | 3.6% | PS1.2x |